Whalen Wealth Management Inc. Astrazeneca PLC Transaction History
Whalen Wealth Management Inc.
- $171 Billion
- Q3 2025
A detailed history of Whalen Wealth Management Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Whalen Wealth Management Inc. holds 9,719 shares of AZN stock, worth $808,815. This represents 0.44% of its overall portfolio holdings.
Number of Shares
9,719Holding current value
$808,815% of portfolio
0.44%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,425Shares Held
498MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.32 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.43 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.86 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.61 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.59 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $258B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...